Search results for: NICE
Filter search results
NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?
7 January 2020
The National Institute of Health and Care Excellence (NICE) makes recommendations for the use of interventions including medicines in the National Health Service in England based on their clinical and…
New NICE Position Statement – 5L Value Set Still ‘On Hold’
29 November 2018
NICE has issued a new position statement regarding the use of the EQ-5D-5L value set in evidence submitted to its HTA process. NICE has issued a new position statement regarding…
New Publication: Assessing Evidence and Access Associated with NICE HTA Decisions Categorised as “Recommended in Line with Clinical Practice”
6 January 2017
A new OHE Research Paper assesses the nature of evidence used to reach HTA decisions which NICE have classified as “Recommended in Line with Clinical Practice” between 2007 and mid-2016….
Shedding the Pounds: Obesity Management, NICE Guidance and Bariatric Surgery in England
1 November 2010
In December 2006, the National Institute for Health and Clinical Excellence (NICE) issued guidance for preventing and managing overweight and obesit. Recommendations are step-wise, starting with lifestyle changes and progressing…
An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’
1 December 2016
This Research Paper explores decisions by the National Institute for Health and Care Excellence (NICE) that new technologies are to be recommended in line with clinical practice (RiLCP). The authors…
Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?
1 February 2017
In 2016 the University of York undertook a review exercise to determine whether NICE’s existing methods and processes are appropriate for assessment of regenerative medicines. The purpose of this OHE…
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
1 September 2021
…and Care Excellence (NICE) by providing an auxiliary appraisal route for highly specialized technologies. However, concerns have been raised regarding the appraisals of medicines that don’t meet the strict criteria…
Spotlight on OHE: NICE, Biosimilars, HTA
17 June 2014
…of recent conferences and meetings has contributed to discussions on a range of important issue in health economics. Changes in NICE decision making The consultation process for changes in how…
Spotlight on OHE: Opportunity Costs of NICE Decisions in Wales and HESG 2015
20 January 2015
Jon Sussex presents on the opportunity costs of implementing NICE decisions in Wales, and OHE attend HESG in Leeds, January 2015. Opportunity costs of implementing NICE decisions in NHS Wales…